For this purpose, we twice stimulated, at 1-week intervals, lung cancer patient PBMCs with each of the four peptides and then evaluated generation of ppCT-specific CTLs by intracellular IFN-γ staining or the enzyme-linked immunospot (Elispot) assay. This evidence concerns the gene IFNG and lung cancer.